An evaluation of continuous subcutaneous infusions across seven NHS acute hospitals: is there potential for 48-hour infusions?
Abstract Background Continuous subcutaneous infusions (CSCIs) are commonly used in the United Kingdom as a way of administering medication to patients requiring symptom control when the oral route is compromised. These infusions are typically administered over 24 h due to currently available safety...
Main Authors: | J. Baker, A. Dickman, S. Mason, M. Bickerstaff, R. Jackson, A. McArdle, I. Lawrence, F. Stephenson, N. Paton, J. Kirk, B. Waters, J. Ellershaw |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-07-01
|
Series: | BMC Palliative Care |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12904-020-00611-3 |
Similar Items
-
Comparative study of the adverse effects of subcutaneous and intraveneous infusion in patients admitted to neurology ward
by: Simin Jahani, et al.
Published: (2009-10-01) -
Complications of the subcutaneous route in the infusion of medications and solutions in palliative care
by: Natália de Almeida Barbosa Guedes, et al.
Published: (2019-09-01) -
Subcutaneous vitamin B12 administration using a portable infusion pump in cobalamin-related remethylation disorders: a gentle and easy to use alternative to intramuscular injections
by: Amelie S. Lotz-Havla, et al.
Published: (2021-05-01) -
Continuous subcutaneous infusion for pain control in dying patients: experiences from a tertiary palliative care center
by: Per Fürst, et al.
Published: (2020-11-01) -
Safety of an ultra-rush subcutaneous immunotherapy using an infusion pump in real-life
by: Silvia Uriarte, et al.
Published: (2018-06-01)